What is Trazodone and How to Recommend It
Trazodone is an FDA-approved antidepressant for major depressive disorder (MDD) in adults, but you should NOT recommend it for insomnia treatment despite its widespread off-label use for this purpose. 1
What Trazodone Is
Trazodone is a triazolopyridine derivative classified as a serotonin antagonist and reuptake inhibitor (SARI) 2. It works through multiple mechanisms:
- Serotonin modulation: Blocks 5-HT2 receptors and weakly inhibits serotonin reuptake
- Adrenergic effects: Blocks alpha-1-adrenergic receptors
- Histamine blockade: Blocks H1 receptors, contributing to sedation 3, 4
This multimodal action produces sedative, anxiolytic, and antidepressant effects at different doses 3.
FDA-Approved Indication
Trazodone is only approved for treating major depressive disorder in adults 2. It is NOT FDA-approved for insomnia, despite being commonly prescribed off-label for this purpose 1.
How NOT to Recommend It: The Insomnia Problem
The American Academy of Sleep Medicine (2017) explicitly recommends AGAINST using trazodone for sleep onset or sleep maintenance insomnia 1. This is a WEAK recommendation, but critical to understand:
Why the guideline recommends against it:
- Only one trial (50 mg dose) met quality criteria
- Sleep improvements were clinically insignificant: reduced sleep latency by only 10.2 minutes, increased total sleep time by only 21.8 minutes
- Harms potentially outweigh benefits given lack of demonstrated efficacy
- High adverse event rate: 75% of patients experienced side effects vs 65.4% on placebo
- Common side effects: headache (30% vs 19% placebo), somnolence (23% vs 8% placebo) 1
The clinical paradox:
Despite this evidence, physicians continue prescribing trazodone for insomnia because it's perceived as "safer" than benzodiazepines 1. This perception is not supported by quality evidence for insomnia treatment.
How TO Recommend It: For Depression
When prescribing trazodone for its approved indication (MDD), follow this approach:
Dosing Strategy
For antidepressant effect:
- Start: 150 mg/day in divided doses
- Titrate: Increase by 50 mg/day every 3-4 days
- Target: 150-300 mg/day for full antidepressant effect
- Maximum: 400 mg/day (outpatient); 600 mg/day (inpatient) 3, 4
For sedation/anxiolysis (as part of depression treatment):
- Low doses (25-75 mg) produce sedative effects 3
Administration
- Take shortly after a meal or light snack to optimize absorption 2
- Available as immediate-release (can be split along score line) or extended-release formulations
- Swallow whole or break in half; do NOT crush or chew 2
Critical Safety Considerations
Absolute Contraindications
Do NOT prescribe if:
- Currently taking MAOIs or stopped MAOI within 14 days
- Do NOT start MAOI within 14 days of stopping trazodone 2
Use with Extreme Caution in:
Cardiac patients:
- Minimal effect on cardiac conduction 5
- Can cause orthostatic hypotension (especially elderly or those with heart disease) 4
- May lower heart rate 5
- Rare QT prolongation and torsade de pointes reported 4
- Lower doses (100-300 mg) better tolerated in patients with cardiovascular disease 5
Risk of serotonin syndrome:
- High risk when combined with other serotonergic agents (SSRIs, SNRIs, MAOIs, triptans, tramadol, St. John's Wort) 2, 6, 7
- Case reports document serotonin syndrome with trazodone + lurasidone + valproic acid 6 and with rapid titration alongside sertraline and risperidone 7
- Monitor for: agitation, confusion, tremor, muscle rigidity, hyperthermia, autonomic instability
Other warnings:
- Priapism: Rare but serious; requires immediate medical attention 4
- Suicidal ideation: Black box warning for increased risk in children, adolescents, and young adults <25 years 2
- Hepatic/renal impairment: Use with caution; not studied in these populations 2
- Elderly: Increased risk of hyponatremia and orthostatic hypotension 2
Overdose Risk
Trazodone overdose can cause severe, persistent hypotension requiring aggressive fluid resuscitation, vasopressors, and ICU admission 8. However, it is relatively safer in overdose compared to tricyclic antidepressants 9.
Advantages Over Other Antidepressants
When treating depression, trazodone offers:
- Weight neutral (doesn't cause weight gain) 3
- Low risk of sexual dysfunction (unlike SSRIs) 3, 4
- Minimal anticholinergic effects 4
- Limited withdrawal symptoms 3
- Helps with sleep disturbances that accompany depression 4
Patient Counseling Points
- Take with food to reduce side effects and improve absorption
- Expect drowsiness, especially initially; avoid driving until you know how it affects you
- Rise slowly from sitting/lying to prevent dizziness from blood pressure drops
- Report immediately: painful erections lasting >4 hours, thoughts of self-harm, severe dizziness
- Do NOT stop abruptly; taper under physician guidance 2
- Avoid alcohol and other CNS depressants
The Bottom Line Algorithm
For MDD in adults:
- ✓ Start 150 mg/day divided doses with food
- ✓ Titrate to 150-300 mg/day for antidepressant effect
- ✓ Monitor for orthostatic hypotension, especially in elderly/cardiac patients
- ✓ Screen for drug interactions (especially serotonergic agents)
For insomnia (off-label):
- ✗ Do NOT recommend as first-line or routine treatment 1
- Consider FDA-approved alternatives (eszopiclone, zolpidem, doxepin 3-6 mg, suvorexant) that have demonstrated efficacy
Special populations: